Literature DB >> 19194015

Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

Thomas F Lerch1, Qing Xie, Heather M Ongley, Joan Hare, Michael S Chapman.   

Abstract

Adeno-associated viruses (AAVs) are leading candidate vectors for gene-therapy applications. The AAV-3b capsid is closely related to the well characterized AAV-2 capsid (87% identity), but sequence and presumably structural differences lead to distinct cell-entry and immune-recognition properties. In an effort to understand these differences and to perhaps harness them, diffraction-quality crystals of purified infectious AAV-3b particles have been grown and several partial diffraction data sets have been recorded. The crystals displayed varying levels of merohedral twinning that in earlier times would have rendered them unsuitable for structure determination, but here is shown to be a tractable complication.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194015      PMCID: PMC2635862          DOI: 10.1107/S1744309109000372

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  44 in total

1.  The adeno-associated virus crystal: impact inversely proportional to size.

Authors:  Joseph E Rabinowitz; R Jude Samulski
Journal:  Mol Ther       Date:  2002-10       Impact factor: 11.454

2.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

Review 4.  Virus crystallography.

Authors:  E E Fry; J Grimes; D I Stuart
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

5.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

Authors:  K Erles; P Sebökovà; J R Schlehofer
Journal:  J Med Virol       Date:  1999-11       Impact factor: 2.327

8.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4.

Authors:  Nikola Kaludov; Eric Padron; Lakshmanan Govindasamy; Robert McKenna; John A Chiorini; Mavis Agbandje-McKenna
Journal:  Virology       Date:  2003-02-01       Impact factor: 3.616

9.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

10.  Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.

Authors:  Shaun R Opie; Kenneth H Warrington; Mavis Agbandje-McKenna; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  11 in total

1.  Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).

Authors:  Thomas F Lerch; Michael S Chapman
Journal:  Virology       Date:  2011-12-09       Impact factor: 3.616

2.  Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5 Å resolution.

Authors:  Thomas F Lerch; Jason K O'Donnell; Nancy L Meyer; Qing Xie; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Structure       Date:  2012-06-21       Impact factor: 5.006

Review 3.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

4.  The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

Authors:  Thomas F Lerch; Qing Xie; Michael S Chapman
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

5.  AAV's anatomy: roadmap for optimizing vectors for translational success.

Authors:  Angela M Mitchell; Sarah C Nicolson; Jayme K Warischalk; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2010-10       Impact factor: 4.391

Review 6.  Cryo-electron Microscopy of Adeno-associated Virus.

Authors:  Scott M Stagg; Craig Yoshioka; Omar Davulcu; Michael S Chapman
Journal:  Chem Rev       Date:  2022-05-16       Impact factor: 72.087

7.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9.

Authors:  Matthew Mitchell; Hyun-Joo Nam; Adam Carter; Angela McCall; Chelsea Rence; Antonette Bennett; Brittney Gurda; Robert McKenna; Mark Porter; Yoshihisa Sakai; Barry J Byrne; Nicholas Muzyczka; George Aslanidi; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-06-27

Review 8.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

Review 9.  Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering.

Authors:  Dwaipayan Sen
Journal:  J Biomed Sci       Date:  2014-11-26       Impact factor: 8.410

10.  Recovery of data from perfectly twinned virus crystals revisited.

Authors:  Helen Mary Ginn; David Ian Stuart
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-05-25       Impact factor: 7.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.